Pfizer focus on costs to deliver another $1.5 billion in savings

A new  cost-cutting campaign from New York-based Pfizer (NYSE: PFE) demonstrates the intensity of the firm’s focus on ensuring operational efficiencies.

The company has already announced a rationalization and “realignment” program, which is in full swing and  on track to deliver around $4 billion in savings by the end of this year.

Pfizer has now said it will engage in a separate, “multi-year program” to reduce the cost of goods sold, targeting operational efficiencies, network structure changes, and product portfolio enhancements.